Unum Therapeutics Inc.
Unum Therapeutics Inc. (UMRX) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 38 transactions totaling $11.6M, demonstrating a bullish sentiment with $10.7M in net insider flow. The most recent transaction on Aug 18, 2020 involved a purchase of 101,000 shares valued at $264.6K.
UMRX Insider Activity Summary
Who Is Buying UMRX Stock?
No significant insider buying has been recorded for UMRX in the recent period.
Who Is Selling UMRX Stock?
No significant insider selling has been recorded for UMRX in the recent period.
Is Unum Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for UMRX is bullish with an Insider Alignment Score of 96/100 and a net flow of $10.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
UMRX Frequently Asked Questions
Understanding UMRX Insider Activity
Insider trading at Unum Therapeutics Inc. (UMRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading UMRX stock, having executed 38 transactions in the past 90 days. The most active insider is Liam Ratcliffe (Executive), who has made 4 transactions totaling $6.6M.
Related Tools
Track Unum Therapeutics Inc. Insider Activity
Get notified when executives and directors at UMRX file new Form 4 transactions